These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 14985462

  • 21. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells.
    Kern MA, Schubert D, Sahi D, Schöneweiss MM, Moll I, Haugg AM, Dienes HP, Breuhahn K, Schirmacher P.
    Hepatology; 2002 Oct; 36(4 Pt 1):885-94. PubMed ID: 12297835
    [Abstract] [Full Text] [Related]

  • 22. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
    Kawamori T, Rao CV, Seibert K, Reddy BS.
    Cancer Res; 1998 Feb 01; 58(3):409-12. PubMed ID: 9458081
    [Abstract] [Full Text] [Related]

  • 23. Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines.
    Kardosh A, Blumenthal M, Wang WJ, Chen TC, Schönthal AH.
    Cancer Biol Ther; 2004 Jan 01; 3(1):55-62. PubMed ID: 14726653
    [Abstract] [Full Text] [Related]

  • 24. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL.
    Cancer Res; 2002 Feb 01; 62(3):625-31. PubMed ID: 11830509
    [Abstract] [Full Text] [Related]

  • 25. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.
    Williams CS, Watson AJ, Sheng H, Helou R, Shao J, DuBois RN.
    Cancer Res; 2000 Nov 01; 60(21):6045-51. PubMed ID: 11085526
    [Abstract] [Full Text] [Related]

  • 26. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells.
    Narayanan BA, Narayanan NK, Simi B, Reddy BS.
    Cancer Res; 2003 Mar 01; 63(5):972-9. PubMed ID: 12615711
    [Abstract] [Full Text] [Related]

  • 27. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.
    Levitt RJ, Buckley J, Blouin MJ, Schaub B, Triche TJ, Pollak M.
    Biochem Biophys Res Commun; 2004 Apr 02; 316(2):421-8. PubMed ID: 15020235
    [Abstract] [Full Text] [Related]

  • 28. Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells.
    Levitt RJ, Pollak M.
    Cancer Res; 2002 Dec 15; 62(24):7372-6. PubMed ID: 12499282
    [Abstract] [Full Text] [Related]

  • 29. Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9.
    Ding H, Han C, Zhu J, Chen CS, D'Ambrosio SM.
    Int J Cancer; 2005 Feb 20; 113(5):803-10. PubMed ID: 15499625
    [Abstract] [Full Text] [Related]

  • 30. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
    Erickson BA, Longo WE, Panesar N, Mazuski JE, Kaminski DL.
    J Surg Res; 1999 Jan 20; 81(1):101-7. PubMed ID: 9889067
    [Abstract] [Full Text] [Related]

  • 31. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
    Leng J, Han C, Demetris AJ, Michalopoulos GK, Wu T.
    Hepatology; 2003 Sep 20; 38(3):756-68. PubMed ID: 12939602
    [Abstract] [Full Text] [Related]

  • 32. 3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells.
    Kulp SK, Yang YT, Hung CC, Chen KF, Lai JP, Tseng PH, Fowble JW, Ward PJ, Chen CS.
    Cancer Res; 2004 Feb 15; 64(4):1444-51. PubMed ID: 14973075
    [Abstract] [Full Text] [Related]

  • 33. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2.
    Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS.
    J Biol Chem; 2000 Apr 14; 275(15):11397-403. PubMed ID: 10753955
    [Abstract] [Full Text] [Related]

  • 34. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.
    Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, Hafeli UO, Fu P, Mukhtar H.
    Cancer Res; 2004 May 01; 64(9):3334-43. PubMed ID: 15126378
    [Abstract] [Full Text] [Related]

  • 35. Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.
    Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT.
    J Neurosurg; 2005 Sep 01; 103(3):508-17. PubMed ID: 16235684
    [Abstract] [Full Text] [Related]

  • 36. Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma.
    Wun T, McKnight H, Tuscano JM.
    Leuk Res; 2004 Feb 01; 28(2):179-90. PubMed ID: 14654083
    [Abstract] [Full Text] [Related]

  • 37. From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors.
    Zhu J, Huang JW, Tseng PH, Yang YT, Fowble J, Shiau CW, Shaw YJ, Kulp SK, Chen CS.
    Cancer Res; 2004 Jun 15; 64(12):4309-18. PubMed ID: 15205346
    [Abstract] [Full Text] [Related]

  • 38. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.
    Shishodia S, Aggarwal BB.
    Cancer Res; 2004 Jul 15; 64(14):5004-12. PubMed ID: 15256475
    [Abstract] [Full Text] [Related]

  • 39. The role of COX-2 inhibition in breast cancer treatment and prevention.
    Arun B, Goss P.
    Semin Oncol; 2004 Apr 15; 31(2 Suppl 7):22-9. PubMed ID: 15179621
    [Abstract] [Full Text] [Related]

  • 40. Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest.
    Han C, Leng J, Demetris AJ, Wu T.
    Cancer Res; 2004 Feb 15; 64(4):1369-76. PubMed ID: 14973068
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.